Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him

 
• By Sten Stovall
Daniel O Day
O'Day Seen Bringing Valuable M&A, Oncology Experience To Gilead

More from Executives On The Move

More from Leadership